USA CDC on COVID-19 Vaccine-Related Deaths

Recent revelations from The Epoch Times shed light on a controversial issue surrounding COVID-19 vaccines in the United States. According to internal documents obtained by the publication, the officials at the U.S. Centers for Disease Control and Prevention (CDC) found evidence linking Pfizer-BioNTech and Moderna COVID-19 vaccines to multiple deaths, particularly due to myocarditis, a confirmed side effect of the vaccines.

The investigation conducted by CDC employees revealed concerning findings. Some death certificates and autopsies indicated myocarditis as a cause of death post-vaccination, while in other cases, myocarditis was listed as being caused by vaccination. Furthermore, there were cases of deaths linked with the CDC’s definition for myocarditis, occurring within 42 days of vaccine administration and lacking virus-related symptoms. Dr. Clare Craig, a British pathologist, emphasized the significance of these findings, stating that in cases meeting specific criteria, it is safe to conclude that the vaccines caused the deaths. However, despite these findings, the CDC maintained that there was no evidence linking the Moderna and Pfizer mRNA vaccines to reported deaths. Critics, including heart expert Dr. Andrew Bostom, have condemned the CDC’s stance, accusing the agency of concealing vaccine-related deaths. The discrepancies between reported deaths and the CDC’s official stance raise questions about transparency and accountability in public health messaging.

Moreover, the file obtained through a Freedom of Information Act request underscores the CDC’s investigation into reports of myocarditis and pericarditis following COVID-19 vaccination. Among the cases examined, a significant number resulted in death, highlighting the severity of the issue. Individual cases outlined in the file provide examples of vaccine-related deaths. From a 37-year-old man experiencing symptoms shortly after receiving the Moderna vaccine to a 24-year-old diagnosed with myocarditis after a second Pfizer injection, these instances underscore the complexity of the issue. However, challenges remain in establishing causality definitively. In some cases, comorbidities and concurrent medical conditions complicate the assessment of vaccine-related deaths. The reluctance of medical examiners to comment on specific cases further adds to the complexity of the situation.

As the debate over vaccine safety continues, it is imperative to prioritize transparency, thorough investigation, and open dialogue. Addressing concerns surrounding vaccine-related adverse events is crucial for fostering public trust and ensuring the integrity of vaccination programs. Only through transparent and evidence-based communication can we navigate the complexities of vaccine safety and protect public health effectively.